RESTON, VA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)AMERICAN BRACHYTHERAPY SOCIETY, founded in 1978, is a community nonprofit that reported $1.1M in total revenue in fiscal year 2023. Revenue surged 21% from the prior year, signaling strong growth momentum. Expenses of $938K left a modest 11% surplus.
THE PURPOSE OF THE ABS IS TO SERVE ITS MEMBERS BY ADVANCING THE FIELD OF BRACHYTHERAPY, BY PROMOTING EXCELLENCE IN EDUCATION, RESEARCH AND CLINICAL PRACTICE, AND BY REPRESENTING BRACHYTHERAPY SPECIALISTS AND THEIR PATIENTS.
CONFERENCES THE SOCIETY HOLDS ANNUAL MEETINGS AT WHICH ARE DESIGNED TO ADVANCE RESEARCH IN THE FIELD OF BRACHYTHERAPY. OBJECTIVES OF THE MEETING INCLUDE DISCUSSING ESTABLISHED AND EMERGING...
CONFERENCES THE SOCIETY HOLDS ANNUAL MEETINGS AT WHICH ARE DESIGNED TO ADVANCE RESEARCH IN THE FIELD OF BRACHYTHERAPY. OBJECTIVES OF THE MEETING INCLUDE DISCUSSING ESTABLISHED AND EMERGING INDICATIONS FOR BRACHYTHERAPY TREATMENT FOR CANCER, REVIEWING THE CURRENT SOCIETY'S GUIDELINES FOR BRACHYTHERAPY AND THE LITERATURE SUPPORTING THESE MODALITIES, CONTROVERSIES, AVAILABLE METHODS, AND TOXICITIES, AND UNDERSTANDING THE CHANGING HEALTHCARE ENVIRONMENT AND HOW IT WILL IMPACT REIMBURSEMENT FOR BRACHYTHERAPY.ANNUAL MEETING LEARNING OBJECTIVES:1. DISCUSS ESTABLISHED AND EMERGING INDICATIONS FOR BRACHYTHERAPY TREATMENT FOR CANCER2. REVIEW TECHNICAL APPROACHES FOR BRACHYTHERAPY SOURCE AND APPLICATOR INSERTION3. REVIEW THE CURRENT AMERICAN BRACHYTHERAPY SOCIETY'S GUIDELINES FOR BRACHYTHERAPY AND THE LITERATURE SUPPORTING THOSE MODALITIES, CONTROVERSIES, AVAILABLE METHODS AND TOXICITIES4. UNDERSTAND NEW IMAGING MODALITIES AND HOW THESE CAN IMPACT BRACHYTHERAPY PROCEDURES AND TREATMENT PLANNING5. DESCRIBE THE POTENTIAL ROLE OF SOCIAL MEDIA IN A MODERN BRACHYTHERAPY PRACTICE6. LEARN ABOUT STRATEGIES FOR INCORPORATING PEER REVIEW INTO A BRACHYTHERAPY PRACTICE7. UNDERSTAND THE CHANGING HEALTHCARE ENVIRONMENT AND HOW IT WILL IMPACT REIMBURSEMENT FOR BRACHYTHERAPY8. OBTAIN KNOWLEDGE AND HANDS-ON EXPERIENCE IN ANATOMY AND ORGAN SEGMENTATION IN BOTH PROSTATE AND GYNECOLOGIC CARCINOMA AS WELL AS APPLICATION OF BRACHYTHERAPY FOR SKIN CANCERS9. LEARN ABOUT THE CURRENT CAPABILITIES OF BRACHYTHERAPY TREATMENT PLANNING SYSTEMS.10. UNDERSTAND MODERN BRACHYTHERAPY TREATMENT DEVICES AND HOW THESE CAN IMPACT PATIENT CARE.11. UNDERSTAND THE CURRENT DATA REGARDING DIFFERENT FRACTIONATION SCHEDULES AND CLINICAL IMPLICATIONS OF DIFFERENT APPROACHES
SCHOOL PROGRAMS THE SCHOOL PROGRAM'S VISION IS TO INCREASE PATIENT ACCESS TO HIGH QUALITY PROSTATE BRACHYTHERAPY. THEIR GOALS ARE TO IMPROVE EDUCATION AND TRAINING OF HDR/LDR BRACHYTHERAPY, TO...
SCHOOL PROGRAMS THE SCHOOL PROGRAM'S VISION IS TO INCREASE PATIENT ACCESS TO HIGH QUALITY PROSTATE BRACHYTHERAPY. THEIR GOALS ARE TO IMPROVE EDUCATION AND TRAINING OF HDR/LDR BRACHYTHERAPY, TO FACILITATE A MORE RAPID TRANSITION FROM EDUCATION TO PRACTICE IMPLEMENTATION, TO ENSURE HIGH QUALITY BRACHYTHERAPY DELIVERY, AND TO COMMUNICATE THE VALUE OF BRACHYTHERAPY.GOALS:- TO IMPROVE EDUCATION AND TRAINING OF HDR/LDR BRACHYTHERAPY- TO FACILITATE A MORE RAPID TRANSITION FROM EDUCATION TO PRACTICE IMPLEMENTATION- TO ENSURE HIGH QUALITY BRACHYTHERAPY DELIVERY- TO COMMUNICATE THE VALUE OF BRACHYTHERAPY
PUBLICATIONS THE SOCIETY PUBLISHES THE JOURNAL "BRACHYTHERAPY", AN INTERNATIONAL AND MULTIDISCIPLINARY JOURNAL. "BRACHYTHERAPY" PUBLISHES ORIGINAL PEER-REVIEWED ARTICLES AND LABORATORY AND...
PUBLICATIONS THE SOCIETY PUBLISHES THE JOURNAL "BRACHYTHERAPY", AN INTERNATIONAL AND MULTIDISCIPLINARY JOURNAL. "BRACHYTHERAPY" PUBLISHES ORIGINAL PEER-REVIEWED ARTICLES AND LABORATORY AND EXPERIMENTAL RESEARCH RELEVANT TO CLINICAL PRACTICE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $1,051,253 | $872,051 | +0.2% |
| Expenses | $937,918 | $717,267 | +0.3% |
| Net Income | $113,335 | $154,784 | -0.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| BRETT COX MD | PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| MIRA KEYES MD | PRESIDENT-ELECT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| MITCHELL KAMRAVA MD | VICE PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| PETER ROSSI MD | CHAIRMAN OF THE BOARD | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| CHRISTOPHER DEUFEL PHD | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| KRISTIN BRADLEY MD | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JUNZO CHINO MD | DIRECTOR-AT-LARGE | 1.00 |
Director
|
$0 | $0 | $0 |
| MARISSA KOLLMEIER | DIRECTOR-AT-LARGE | 1.00 |
Director
|
$0 | $0 | $0 |
| JYOTI MAYADEV MD | DIRECTOR-AT-LARGE | 1.00 |
Director
|
$0 | $0 | $0 |
| CHRISTINE FISHER MD | DIRECTOR-AT-LARGE | 1.00 |
Director
|
$0 | $0 | $0 |
| MELISSA POMERENE | EXECUTIVE DIRECTOR | 20.00 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $1,051,253 | $937,918 | $1,802,878 | $113,335 |
| 2022 | $872,051 | $717,267 | $1,500,464 | $154,784 |
| 2021 | $651,017 | $634,805 | $1,446,468 | $16,212 |
| 2020 | $409,734 | $435,258 | $1,303,340 | $-25,524 |
| 2019 | $1,154,781 | $989,348 | $1,338,045 | $165,433 |
| 2018 | $1,091,304 | $949,939 | $1,055,722 | $141,365 |
Compare AMERICAN BRACHYTHERAPY SOCIETY with other nonprofits in Virginia and across the country.